Literature DB >> 23986128

Identification of Mycobacterium tuberculosis from pericardial fluid using the new Xpert MTB/RIF assay.

Ashar Vijay Dhana1, Pauline Howell, Ian Sanne, David Spencer.   

Abstract

Extrapulmonary tuberculosis (EPTB) is common in HIV-infected patients, especially at lower CD4 cell counts, yet is often difficult to diagnose with certainty. A 35-year-old man presented with dyspnoea and constitutional symptoms of tuberculosis (TB). Laboratory investigations included a positive HIV test and a CD4 cell count of 138 cells/μL. Chest radiography revealed a globular-shaped heart and bilateral pleural effusions, while echocardiography confirmed a massive pericardial effusion. The new Xpert MTB/RIF (Xpert) assay detected rifampicin-sensitive Mycobacterium tuberculosis in pericardial as well as sputum samples. Smear of the pericardial sample was negative. The patient was started on anti-TB treatment and is presently well. He will initiate antiretroviral therapy after 4-6 weeks. To the best of our knowledge, this is the first case report of EPTB diagnosed on pericardial fluid using the Xpert assay in Africa. This report also summarises the use of this assay in the diagnosis of EPTB in HIV-associated TB.

Entities:  

Mesh:

Year:  2013        PMID: 23986128      PMCID: PMC3762401          DOI: 10.1136/bcr-2013-200615

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.

Authors:  Arzu N Zeka; Sezai Tasbakan; Cengiz Cavusoglu
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

3.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

4.  Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis.

Authors:  Manuel Causse; Pilar Ruiz; Juan Bautista Gutiérrez-Aroca; Manuel Casal
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

5.  Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Authors:  Viral Vadwai; Catharina Boehme; Pamela Nabeta; Anjali Shetty; David Alland; Camilla Rodrigues
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

6.  Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

7.  Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis.

Authors:  Enrico Tortoli; Cristina Russo; Claudio Piersimoni; Ester Mazzola; Paola Dal Monte; Michela Pascarella; Emanuele Borroni; Alessandra Mondo; Federica Piana; Claudio Scarparo; Luana Coltella; Giulia Lombardi; Daniela M Cirillo
Journal:  Eur Respir J       Date:  2012-01-12       Impact factor: 16.671

Review 8.  Tuberculous pericarditis.

Authors:  Bongani M Mayosi; Lesley J Burgess; Anton F Doubell
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

Review 9.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

10.  Tuberculous pericarditis in Tanzanian patients with and without HIV infection.

Authors:  J P Cegielski; J Lwakatare; C S Dukes; L E Lema; G J Lallinger; J Kitinya; L B Reller; F Sheriff
Journal:  Tuber Lung Dis       Date:  1994-12
View more
  5 in total

Review 1.  Economic challenges associated with tuberculosis diagnostic development.

Authors:  Colleen F Hanrahan; Maunank Shah
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-04-28       Impact factor: 2.217

2.  Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.

Authors:  Shaheen Pandie; Jonathan G Peter; Zita S Kerbelker; Richard Meldau; Grant Theron; Ureshnie Govender; Mpiko Ntsekhe; Keertan Dheda; Bongani M Mayosi
Journal:  BMC Med       Date:  2014-06-18       Impact factor: 8.775

3.  Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-γ release assays for tuberculous pericarditis using pericardial tissue.

Authors:  Guocan Yu; Bo Ye; Da Chen; Fangming Zhong; Gang Chen; Jun Yang; Liliang Xu; Xudong Xu
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

4.  Diagnostic values of Xpert MTB/RIF, T-SPOT.TB and adenosine deaminase for HIV-negative tuberculous pericarditis in a high burden setting: a prospective observational study.

Authors:  Xu Hu; Baochun Xing; Wei Wang; Pengwei Yang; Yumei Sun; Xiangyang Zheng; Yaomin Shang; Feifei Chen; Nai Liu; Lu Yang; Yue Zhao; Jiao Tan; Xueya Zhang; Yan Wang; Zhengxun Zhang; Yaqian Liu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

Review 5.  Tuberculous Pericarditis-Own Experiences and Recent Recommendations.

Authors:  Małgorzata Dybowska; Katarzyna Błasińska; Juliusz Gątarek; Magdalena Klatt; Ewa Augustynowicz-Kopeć; Witold Tomkowski; Monika Szturmowicz
Journal:  Diagnostics (Basel)       Date:  2022-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.